You are here » Home » Companies » Company Overview » Nectar Lifescience Ltd

Nectar Lifescience Ltd.

BSE: 532649 Sector: Health care
NSE: NECLIFE ISIN Code: INE023H01027
BSE LIVE 15:51 | 21 Aug 26.70 -0.80
(-2.91%)
OPEN

27.10

HIGH

27.75

LOW

26.50

NSE 15:50 | 21 Aug 26.75 -0.70
(-2.55%)
OPEN

27.45

HIGH

27.65

LOW

26.55

OPEN 27.10
PREVIOUS CLOSE 27.50
VOLUME 111089
52-Week high 43.65
52-Week low 24.00
P/E 11.27
Mkt Cap.(Rs cr) 599
Buy Price 26.70
Buy Qty 997.00
Sell Price 0.00
Sell Qty 0.00
OPEN 27.10
CLOSE 27.50
VOLUME 111089
52-Week high 43.65
52-Week low 24.00
P/E 11.27
Mkt Cap.(Rs cr) 599
Buy Price 26.70
Buy Qty 997.00
Sell Price 0.00
Sell Qty 0.00

Nectar Lifescience Ltd. (NECLIFE) - Chairman Speech

Company chairman speech

NECTAR LIFESCIENCES LIMITED ANNUAL REPORT 2006-2007 CHAIRMAN'S REPORT Dear Shareholders. I am delighted to inform you that your company, in line with our objectives, has yet again recorded very consistent and vibrant performance during the financial year 2006-07. During the year 2006-07, your company achieved sales turnover of Rs. 46518.14 Lacs registering 62.61% increase over the previous year (Rs.28606.85 lacs). Income before interest and depreciation increased to Rs. 9139.65 lacs registering 89.59% increase over the previous year (Rs. 4820.81 lacs). The net profit increased to Rs. 4835.82 lacs registering 89.27% increase over the previous year (Rs 2555.01 lacs). Your Directors expect a consistent growth in company's performance in the years to come. The most remarkable feature of the performance of your company has been the quality of our performance particularly in exports. During the previous year, distribution of sales was 67% domestic and 33% exports. This year exports have upsurged to 45% with domestic at 55%. We expect this trend to further accelerate more towards exports with an estimated 60:40 split between exports & domestic in the next financial year. As a part of one of the fastest growing economies of the world i.e. India, our aspirations and aim is to be in sync & contribute that very little but significant part to India's increasing global presence besides catering to one of most robust domestic consuming market of the world. One of the most significant aspect of this year has been marked improvement in performance of your company through ongoing expansion of the global business which includes presence in both the regulated markets like US, Europe & the most happening BRIC (Brazil, Russia, India & China) markets besides 35 other geographies of the world. This rapid growth of your company is greatly attributed to a tremendous amount of cohesion between the management team as well as dedication and exemplary hard work put in by a highly skilled team of officers/executives, work force and other stakeholders of the company. In the lifesciences segment, where India is a very significant player globally, it is extremely essential and important to be a highly integrated player to not only survive in highly competitive environment but also to continue to register a sustainable growth as your company has done over the last few years. In this respect, your company is optimally integrated backwardly through the active pharmaceuticals ingredients segment particularly Cephalosoprins which is the biggest segment of antibiotics/anti bacterials part of pharmaceuticals the world over. In terms of forward integration our plant at Baddi in Himachal Pradesh, India for Finished Dossage Forms (FDF) has already gone on stream. This is a state of the art FDF facility which is comprehensively compliant with the highly stringent requirements of regulatory bodies like US FDA, EDQM , MHRA, MCC, TGA etc to name a few. It has global capacities for both Orals & Steriles forms and it is to the credit of a highly motivated team in your company which has put together an excellent global sized facility in place in record time. This facility strategically positions your company in the CRAMS (Compact Research & Manufacturing Services) segment of Lifesciences in which India has registered the highest segmental growth in Lifesciences industry. Additionally as part of the horizontal expansion, your company has also set up Empty Hard Gelatin Capsules (EHGC) Facility in Baddi which also is one of the most modern and technologically advanced facility. This unit will be the only EHGC unit in Baddi catering captively to practically all major Indian pharma units which are located in and around Baddi, Paonta Saahib, Uttaranchal & other tax exempted zones. The unit has been already operationalised. We expect to expand this unit also to global scale with an eye on the highly lucrative exports market. As a part of our highly successful innovative diversification strategy, your company has emerged as one of the leading global players in phytochemicals & herbal products for Menthol Crystals, Flakes and various derivatives. Within a very short time in this financial year and in the next financial year you will appreciate extremely good and robust contributions from this very important and critical sector, which in a way is also related to pharmaceuticals. Your company is enhancing the capacities of phyto-chemicals to global levels which will contribute significantly to both the top and bottomline of the company in the coming years. I take this opportunity to record my gratitude and appreciate tremendous work put in by one & all of your company right from the worker to the top management for their dedication and highly value added contributions which has collectively led to this robust performance of your company. I am confident that all the stake-holders of the company will continue to register even better performance in the forthcoming eventful year 2007-08 when we can come back to you with even better performance than this financial year. I also take this opportunity to thank all other strategic stake-holders like the financial institutions, investors, our bankers and others without whose help and continued support we would not be able to do what we have done. I am absolutely reassured and confident that we will not only continue to get this support from them but even exceed your expectations so as to enable the company to continue to perform even better. With Warm Regards Yours Sincerely, Place: Chandigarh SANJIV GOYAL Date : 03.09.2007 Chairman & Managing Director